News
2010-04-21
Euro RSCG San Francisco Appointed Interactive AOR for Genentech’s Tamiflu Brand
Euro RSCG San Francisco won the interactive AOR for Genentech’s Tamiflu brand. Tamiflu (Oseltamivir), manufactured by Roche, is currently the market leader in antiviral prescriptions to help treat and prevent the flu, which affects millions of people each year.
Euro RSCG San Francisco will immediately begin work on redesigning and launching the new Tamiflu.com, for consumers and health care professionals, and the unbranded FluFacts.com. This launch will be supported with mobile and social extensions as well as ePRM programs. The win extends Euro RSCG San Francisco’s pharmaceutical experience into the consumer-focused, non-chronic disease realm.
The sites are set to launch in September 2010
More to follow.